Genmab A (GMAB) EBT: 2018-2021
- Genmab A's EBT rose 362.62% to $169.09 in Q2 2021 from the same period last year, while for Jun 2021 it was $356.29, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $685.9 million for FY2020, which is 130.68% up from last year.
- Per Genmab A's latest filing, its EBT stood at $169.09 for Q2 2021, which was up 116.92% from $77.95 recorded in Q4 2020.
- Over the past 5 years, Genmab A's EBT peaked at $25.5 million during Q4 2018, and registered a low of -$11.7 million during Q2 2019.
- For the 3-year period, Genmab A's EBT averaged around -$2.3 million, with its median value being $72.69 (2019).
- In the last 5 years, Genmab A's EBT crashed by 100.00% in 2019 and then spiked by 362.62% in 2021.
- Genmab A's EBT (Quarterly) stood at $25.5 million in 2018, then plummeted by 100.00% to $72.69 in 2019, then increased by 7.23% to $77.95 in 2020, then surged by 362.62% to $169.09 in 2021.
- Its EBT was $169.09 in Q2 2021, compared to $77.95 in Q4 2020 and $36.55 in Q2 2020.
